Karyopharm Therapeutics
Karyopharm Therapeutics, headquartered in Newton, Massachusetts, and established in 2008, is a commercial-stage pharmaceutical company specializing in drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases.
Last updated on
About Karyopharm Therapeutics
Founded
2008Estimated Revenue
$100M-$250MEmployees
251-1KFunding / Mkt. Cap
$959MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
32Location
City
NewtonState
MassachusettsCountry
United StatesTech Stack (91)
.png)
